Cardiology

Anticoagulation seen in about half of sub-segmental PE cases

(HealthDay)—Sub-segmental pulmonary embolism (SSPE) represents a substantial burden of total pulmonary embolisms (PEs), according to research published online Dec. 1 in the Journal of Thrombosis and Haemostasis.

Cardiology

Activity decreases bleeding risk from anticoagulation meds

(HealthDay)—For elderly patients on anticoagulant therapy, a high level of physical activity is associated with a decreased risk of major bleeding, according to a study published online Nov. 18 in the Journal of Thrombosis ...

Cardiology

Patient preference for anticoagulant tx outcome varies

(HealthDay)—Patients' preferences for outcomes of anticoagulation therapy vary and are affected by previous stroke or myocardial infarction experience, according to a study published online Nov. 11 in Circulation: Cardiovascular ...

Cardiology

Vitamin K antagonist plus clopidogrel feasible for PCI

(HealthDay)—Vitamin K antagonists (VKA) combined with clopidogrel may be a better alternative to triple anticoagulant therapy in patients on long-term VKA undergoing percutaneous coronary intervention (PCI) and stenting, ...

Cardiology

New guidance on antithrombotic use in AF patients with ACS

A new European joint consensus document on the use of antithrombotic drugs, including the non-vitamin K antagonist oral anticoagulants (NOACs), in patients with atrial fibrillation (AF) presenting with an acute coronary syndrome ...

Cardiology

Aspirin cuts risk of clots, DVT by a third, new study finds

Low dose aspirin lowers the occurrence of new venous blood clots – and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new ...

page 4 from 7